Washington University in St. Louis and MilliporeSigma Partner to Boost Scientific Research and Innovation

Washington University in St Louis and MilliporeSigma Appeared Together to Bolster Scientific Collaboration

Announcement

The Milliporesigma, the Canadian life science and the US business of Merck KGaA, Darmstadt, Germany, a popular technology and science company, entered into a contract, signing a non-binding memorandum of understanding (MOU) with Washington University in St. Louis (WashU), Missouri, US. The agreement symbolizes the valuable move towards the next chapter in a long-lasting partnership motivated to advancing innovation and scientific research. The extensive partnership will contribute to the joint research initiatives, research availability, and technology scouting with the intention of adopting social and sustainable responsive scientific progress. WashU and MilliporeSigma will work together towards building a strong space in the talent pipeline, help to introduce life-saving therapies to patients quickly, and leverage the transitional efforts from lab discoveries to clinical applications.

By stepping into the partnership milliporesigma will enable access its vast portfolio of products and services, including technical expertise. It is the appreciative contribution to researchers for integrating it with their innovative skills more perfectly and efficiently. The mou also demonstrates milliporesigma’s attempts and support to the early-stage innovation by involving with incubators and startups. It unlocks services to elevate growth and offer venture resources.

Milliporesigma’s Support and WashU’s Efforts

The Washu campus is located near MilliporeSigma’s network of R&D and production sites in St. Louis. At the campus, the company provides employment to nearly 2,300 individuals. In the last five years, the company has been a prominent investor in Washu. The company invested more than $250 million in its St. Louis procedures. This strengthened the regional mark and advanced local scientific capabilities. The MoU emphasizes MilliporeSigma’s commitment to the St. Louis Innovation Ecosystem and its huge mission to bring effective impacts to lives through science.

Views and Statements

CEO of Milliporesigma, Jean-Charles Wirth, said, “The academic industry partnership is more complex than ever in this current scientific landscape. Our collaboration with WashU reflects MilliporeSigma’s commitment to encouraging the future generation of scientists, bolstering progress in life science and healthcare. By merging WashU’s remarkable research ability with our excellent technologies and the company’s expertise, we can accelerate innovation into a lasting impact.”

WashU’s chancellor, Andrew D. Martin, said, “With this agreement, we have achieved one more milestone in the shared history of MilliporeSigma and WashU. This collaboration is central to our university’s scientific and research progress. By initiating a partnership with MilliporeSigma, we have the chance to expand our potential for solutions to the global challenges.”